• A Voice for ME Patients in Europe
    Campaigning for ME in Europe
    Welcome To The Next Level
    OUR PORTFOLIO
  • European ME Alliance
    A Voice for ME Patients in Europe
    ................
    OUR PORTFOLIO
  • 3 ARE YOU READY?
    CREATIVE
    Welcome To The Next Level
    OUR PORTFOLIO

The European ME Alliance gives a voice for people with ME in Europe and is the European partner for high-quality biomedical research into Myalgic Encephalomyelitis (ME).



EMEA
Who We Are

European ME Alliance

The European ME Alliance is a grouping of European organisations who are involved in supporting patients suffering from myalgic encephalomyelitis (ME or ME/CFS) and are campaigning for funding for biomedical research to provide treatments and cures for ME.

The alliance was formed in 2008 by national charities and organisations in Europe.

The Alliance now has representatives from Belgium, Czech Republic, Denmark, Finland, France, Germany, Holland, Iceland, Ireland, Italy, Norway, Spain, Sweden, Switzerland and the UK.

ME/CFS is a debilitating neurological illness classified as such by the World Health Organisation under ICD-10 G93.3.

Our aim is to campaign for appropriate funding of biomedical research into ME/CFS to establish an understanding of the aetiology, pathogenesis and epidemiology of the disease. This should lead to the development of treatments to cure or alleviate the effects of the illness.

Read More

Latest Projects

Check the status of projects organised by EMEA

VIEW MORE

Events

What events are being organised by EMEA

VIEW MORE

Around Europe

What is happening around Europe with regard to ME

VIEW MORE
* Based on an estimate of 0.004 of population

Title

..........................

..............

EMEA

'''''''''''''''''''

LEARN MORE
Title

EMEA

EMEA description

Read more
EMEA

EMEA header

EMEA

LEARN MORE

EMEA

......................

..............

........................................

EMEA Work

EMEA

EMEALayout

EMEA...................................

EMEA0

EMEA

................................